Is Novavax Stock a Buy?
If you purchased just $10,000 in shares of vaccine drugmaker Novavax (NASDAQ: NVAX) at the beginning of the year, your investment would be worth a stunning $304,000 in less than 12 months. That kind of performance is wild, considering a $10,000 investment in its peers, Moderna and BioNTech, would be up only 617% and 208%, respectively.
Many investors are now skeptical of Novavax, as it can be very difficult to buy stocks after they breach new records. After all, shares are down over 30% from all-time highs after its progress fell behind its competitors.
However, ample signals are pointing to a sharp rebound in Novavax stock in the next year. Today, let's look at why the company's momentum is about to pick up exactly where it left off.
Source Fool.com
